In 2009, Dr. Geoffrey Allan earned $1.61M in total compensation at Insmed, including $209.64K salary and $699.58K in stock. Led Insmed as CEO for 3 years.
Compensation History
Annual executive compensation data for Dr. Geoffrey Allan, including salary, bonuses, and stock awards.
Year
2009
Total Compensation
$1.61M
Salary
$209.64K
Bonus
$0.00
Other
$699.58K
Salary
$209.64KBoard Justification
The company's compensation philosophy aims to attract, retain, and motivate highly qualified executives while aligning compensation with shareholder interests and performance metrics.
Bonus
$0.00Board Justification
No bonus was awarded for fiscal 2009 as he was only employed for a partial year before resigning due to health reasons.
Other Compensation
$699.58KBoard Justification
Includes a lump sum severance payment of $675,000 and other benefits related to the personal use of a vehicle provided by the company.
Restricted Stock
Board Justification
The 2008 restricted stock and restricted stock unit grants to Dr. Allan vested on March 31, 2009 as a result of the Merck transaction prior to his resignation.
Performance Metrics
The performance metrics for 2009 included the successful conclusion of the sale of Follow on Biologics assets to Merck, completion of clinical trials, and strategic business reviews.
Dr. Geoffrey Allan
Ex-CEO of Insmed
Education
N/A
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
Born
June 19, 1958 - 67 years ago
CEO of Insmed for
3 years 10 months (Aug 2005 - Jun 2009)
Previous Experience
N/A
Other Insmed CEOs
Holdings
Track Dr. Geoffrey Allan's stock holdings and portfolio value over time.
Insider Trading
Dr. Geoffrey Allan's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Dr. Geoffrey Allan with competitor CEOs and industry peers.